Maternal serum activin A and inhibin A in trisomy 18 pregnancies at 10-14 weeks

被引:2
作者
Spencer, K
Liao, AW
Ong, CYT
Flack, NJ
Nicolaides, KH
机构
[1] Harold Wood Hosp, Dept Clin Biochem, Endocrine Unit, Romford RM3 0BE, Essex, England
[2] Kings Coll London Hosp, Harris Birthright Res Ctr Fetal Med, London SE5 8RX, England
关键词
inhibin; activin; free beta-hCG; PAPP-A; nuchal translucency; trisomy; 18; first trimester; aneuploidy; prenatal screening;
D O I
10.1002/pd.125
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
In 45 cases of trisomy 18 and 493 control pregnancies at 10-14 weeks of gestation, maternal serum inhibin A. total activin A, free beta -hCG and PAPP-A were measured. In the trisomy IS pregnancies the median values were 0.74 MoM for inhibin A, 1.23 MoM for activin A, 0.38 MoM for free beta -hCG and 0.16 MoM for PAPP-A, The degree of deviation from normal in the levels of inhibin and activin is small in comparison with free beta -hCG and PAPP-A and they are therefore unlikely to be of value in improving the sensitivity of 90% for a 1% false-positive rate achieved by screening with fetal nuchal translucency and maternal serum free beta -hCG and PAPP-A. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:571 / 574
页数:4
相关论文
共 22 条
  • [1] Dimeric inhibin a as a marker for Down's syndrome in early pregnancy
    Aitken, DA
    Wallace, EM
    Crossley, JA
    Swanston, IA
    vanPareren, Y
    vanMaarle, M
    Groome, NP
    Macri, JN
    Connor, JM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (19) : 1231 - 1236
  • [2] EXPANDING MULTIPLE MARKER SCREENING FOR DOWNS-SYNDROME TO INCLUDE EDWARDS-SYNDROME
    BARKAI, G
    GOLDMAN, B
    RIES, L
    CHAKI, R
    ZER, T
    CUCKLE, H
    [J]. PRENATAL DIAGNOSIS, 1993, 13 (09) : 843 - 850
  • [3] PRENATAL SCREENING FOR TRISOMY-18 IN THE 2ND TRIMESTER
    CANICK, JA
    PALOMAKI, GE
    OSATHANONDH, R
    [J]. PRENATAL DIAGNOSIS, 1990, 10 (08) : 546 - 548
  • [4] Cuckle HS, 1999, PRENATAL DIAG, V19, P513, DOI 10.1002/(SICI)1097-0223(199906)19:6<513::AID-PD579>3.0.CO
  • [5] 2-L
  • [6] Cuckle HS, 1999, PRENATAL DIAG, V19, P787, DOI 10.1002/(SICI)1097-0223(199908)19:8<787::AID-PD608>3.0.CO
  • [7] 2-U
  • [8] Lambert-Messerlian G M, 1996, J Med Screen, V3, P217
  • [9] Lambert-Messerlian G M, 1996, J Med Screen, V3, P58
  • [10] Lambert-Messerlian GM, 1998, PRENATAL DIAG, V18, P1061, DOI 10.1002/(SICI)1097-0223(199810)18:10<1061::AID-PD404>3.0.CO